Find a Tender · Tender
Compounded mAbs - Cancer Therapies
A public procurement published by Berkshire Healthcare NHS Foundation Trust via Find a Tender.
- —
- Award value
- £216m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 2
- Notices
- Tender
- Stage
Overview
Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Ho…
Key details
- Source
- Find a Tender
- Lifecycle stage
- Tender
- Status
- active
- CPV classification
- —
- Currency
- GBP
- Total award value
- —
- Tender value
- £216,000,000
- First published
- 7 May 2026
- Last updated
- 12 May 2026
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from Berkshire Healthcare NHS Foundation Trust
FAQs about this procurement
Who is the buyer for "Compounded mAbs - Cancer Therapies"?
Compounded mAbs - Cancer Therapies is a UK public-sector procurement published by Berkshire Healthcare NHS Foundation Trust via Find a Tender.
Has "Compounded mAbs - Cancer Therapies" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
What is "Compounded mAbs - Cancer Therapies" worth?
The reported tender value is £216,000,000.
When was "Compounded mAbs - Cancer Therapies" published?
It was first published on 7 May 2026 and last updated on 12 May 2026, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable